Global Growth Stocks With Strong Insider Confidence

In the current global market landscape, U.S. inflation has reached its highest level since 2023, and major stock indexes have shown mixed results with technology shares facing renewed pressure. Amid these conditions, growth companies with high insider ownership are gaining attention as they often reflect strong internal confidence and potential resilience in uncertain economic times.
Top 10 Growth Companies With High Insider Ownership Globally
| Name | Insider Ownership | Earnings Growth |
| Shanghai Biren Technology (SEHK:6082) | 11% | 118.1% |
| SEERS (KOSDAQ:A458870) | 33.2% | 41.5% |
| Meitu (SEHK:1357) | 22.8% | 31.4% |
| Meiko Electronics (TSE:6787) | 19.2% | 27.3% |
| KebNi (OM:KEBNI B) | 11.8% | 82.7% |
| HUMAN MADE (TSE:456A) | 23.9% | 23.4% |
| Gold Circuit Electronics (TWSE:2368) | 30.2% | 38.2% |
| Fulin Precision (SZSE:300432) | 10.4% | 60.7% |
| CD Projekt (WSE:CDR) | 35.2% | 29.4% |
| Biocytogen Pharmaceuticals (Beijing) (SEHK:2315) | 14.0% | 40.4% |
Here’s a peek at a few of the choices from the screener.
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Yonghui Superstores Co., Ltd. operates and owns various supermarkets in China, with a market cap of CN¥25.35 billion.
Operations: Yonghui generates revenue primarily through its supermarket operations across China.
Insider Ownership: 16%
Yonghui Superstores demonstrates potential as a growth company with significant insider ownership. Despite a decline in sales to CNY 13.37 billion, net income rose to CNY 286.87 million, reflecting improved profitability. The company’s earnings are expected to grow significantly at over 100% per year, with profitability anticipated within three years—outpacing market averages. However, revenue growth forecasts of 8.9% annually lag behind the broader Chinese market’s expectations of 17.3%.
Simply Wall St Growth Rating: ★★★★★☆
Overview: Inner Mongolia Furui Medical Science Co., Ltd. operates in the medical science sector and has a market cap of approximately CN¥10.26 billion.
Operations: Unfortunately, the revenue segments for Inner Mongolia Furui Medical Science Co., Ltd. are not provided in the text you shared. If you have more specific details about their revenue sources, I can help summarize them for you.
Insider Ownership: 16.2%
Inner Mongolia Furui Medical Science shows strong growth potential with earnings expected to rise 37.7% annually, surpassing the Chinese market’s 28.3%. Revenue is forecast to grow at 22.9% per year, outpacing the market’s 17.3%. Recent first-quarter results reported CNY 360.14 million in sales and a net income of CNY 31.79 million, indicating solid performance despite low future return on equity projections of 16.4%. The company recently elected new independent directors and approved a profit distribution plan.
Simply Wall St Growth Rating: ★★★★★★
Overview: Chroma ATE Inc. operates in the design, assembly, manufacturing, sales, repair, and maintenance of software and hardware for computers and peripherals as well as computerized automatic test systems and electronic test instruments across Taiwan, China, the United States, and internationally with a market cap of approximately NT$915.12 billion.
Operations: The company’s revenue is primarily derived from its Measuring Instruments Business, which generated NT$54.43 billion, and its Automatic Equipment Department, contributing NT$1.12 billion.
Insider Ownership: 11%
Chroma ATE is poised for significant growth, with earnings forecast to rise 37.18% annually, outpacing the Taiwan market’s 26.9%. Revenue is expected to grow at 34.3% per year, exceeding the market’s 19.3%. The company recently reported strong Q1 results with revenue of TWD 11.86 billion and net income of TWD 3.86 billion, reflecting robust performance despite a highly volatile share price and no recent insider trading activity noted in the past three months.
Key Takeaways
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders.
It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities.
All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com




